What should you know about immunotherapy and bladder cancer?

Immune medicines can be used in selected bladder cancer situations, including disease that is limited to the bladder or disease that has returned or spread. Some treatments are placed into the bladder, while others travel through the bloodstream. The method depends on the tumour’s depth, grade, and response to earlier care.

A cystoscopy and tissue assessment help define the cancer. The team may also consider chemotherapy, bladder removal surgery, or another local treatment. Immunotherapy is not interchangeable with intravesical BCG therapy; each has a different purpose and delivery method.

Tell the team about autoimmune illness, organ problems, infections, medicines, and previous cancer treatment. Ask whether your treatment is bladder-directed or systemic, how it will be monitored, and what changes should be reported between visits.

Keep a symptom record. Immune-related inflammation can affect the bowel, skin, lungs, liver, kidneys, or hormone glands. Urinary symptoms may also relate to the bladder cancer or a procedure, so describe their timing and severity clearly.

Contact the treatment team promptly for fever, worsening breathlessness, persistent diarrhoea, severe abdominal pain, yellow skin, reduced urine, a widespread rash, or unusual weakness. Seek urgent help for severe breathing difficulty, confusion, fainting, or inability to pass urine.

Is the cancer confined to the bladder or has it spread? Which immunotherapy route is being considered, and why? How does it compare with chemotherapy, BCG, or bladder removal surgery for my situation? Which urinary or whole-body symptoms need urgent review?